Therapeutic agent-1

Therapeutic agent-1 is a heteroaryl compound that can be used in Gaucher disease glucocerebrosidase activity enzyme replacement therapy[1].

Product Specifications

CAS Number

[850020-01-8]

UNSPSC

12352005

Hazard Statement

H302-H315-H319

Target

Glycosidase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/therapeutic-agent-1.html

Purity

97.0

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CC1=C(C=CC=C1)NC2=NC(N)=NC(CN(C)C3=CC=CC=C3)=N2

Molecular Formula

C18H20N6

Molecular Weight

320.39

Precautions

P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501

References & Citations

[1]Heteroaryl compounds and their use. WO2018122775

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, protect from light)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-97549MFV500 0.1 mL

Rabbit Polyclonal DZIP3 Antibody [mFluor Violet 500 SE]

Ask

View Details

SI017148B 1 Each

Human TOM1L1 Pre-designed siRNA Set B

Ask

View Details

GTR15335166 1 Vial

Lentiviral human ALDH9A1 shRNA (UAS) - Lentiviral human ALDH9A1 shRNA (UAS, iRFP) (100)

Ask

View Details

249355-ML750 100 µL

NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 750) discontinued

Ask

View Details

248757-ML405 100 µL

MGST2 (Microsomal Glutathione S-Transferase 2, FLJ27438, GST2, MGC14097, MGST-II) (MaxLight 405) discontinued

Ask

View Details

MBS1108342-01 0.02 mg (E-Coli)

Recombinant Human Putative phosphatidylinositol 4-kinase alpha-like protein P2 (PI4KAP2)

Ask

View Details